Categories
Press Release

Veterinary Orthopedic Implants Market Stand Out as the Biggest Contributor to Global Growth

As per a survey conducted by the American Pet Products Association (APPA), around 68% of the U.S. households own a pet. It is estimated that approximately US$ 75.38 Bn will be spent on animal care in 2019. The growing population of pet owners is a primary factor driving the global veterinary orthopedic implants market.

Browse Complete Report [email protected] https://www.fortunebusinessinsights.com/industry-reports/veterinary-orthopedic-implants-market-100718

Pet animals such as dogs and cats majorly suffer from sports injuries, vehicular trauma, and fights among others.  In case of a fracture, orthopedic surgeries such as elbow replacement, total knee replacement, and others help animals to heal their bones. Depending on the intensity of bone fracture, veterinary doctors decide the type of treatment or implant is required.

Key Segmentation:

By Product Type

  • Tibial Plateau Levelling Osteotomy (TPLO) Implants
  • Tibial Tuberosity Advancement (TTA) Implants
  • Advanced Locking Plate System (ALPS)
  • Total Elbow Replacement (TER) Implants
  • Total Knee Replacement Implants

By Application

  • Bone fractures
  • Osteoarthritis
  • Elbow dysplasia
  • Hip dysplasia
  • Patellar luxation

Get PDF Brochure of this [email protected] https://www.fortunebusinessinsights.com/enquiry/sample/veterinary-orthopedic-implants-market-100718

Rising Number of Highly Trained Professionals to Give Tailwinds to the Market in North America

As per the Association for Pet Obesity Prevention, around 59% of cats and 54% of dogs in the U.S. suffered from obesity in the year 2016, which can lead to some type of orthopedic-related concern. The market in North America is expected to emerge dominant through the forecast years owing to the presence of advanced and innovative veterinary orthopedic instruments.

Top Key Players Covered:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the global Veterinary Orthopedic Implants market. Some of the companies operating the global Veterinary Orthopedic Implants market are;

  • DePuy Synthes,
  • Braun Melsungen AG,
  • Fusion Implants,
  • Integra LifeSciences,
  • Orthomed (UK) Ltd,
  • BioMedtrix LLC,
  • Veterinary Orthopedic Implants,
  • EVEROST INC.,
  • KYON Pharma, Inc.

BioMedtrix Partnered with Laboratories Macrimasa-Vet to Increase its Sales and Support New Customers

“The rising incidence of osteoarthritis and bone fractures among animals is likely to augment demand for veterinary orthopedic surgical procedures,” stated a lead analyst at Fortune Business Insights. “Pet owners across the world are increasingly becoming aware of the animal health and are willing to spend on surgical interventions, thus increasing the veterinary orthopedic implants market revenue,” he added.  A veterinary medical device company called Veterinary Orthopedic Implants, Inc. launched a new Elite TPLO plate in June 2018. This plate is available in different sizes and is contoured to match the proximal surface.

More Trending Topics From Fortune Business [email protected]

Veterinary Orthopedic Implants Market to See Incremental Growth with Growing Advancements in Imaging Services for Animals

Home Rehabilitation Products Market to Derive Growth from the Incorporation of Automated Concepts

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: [email protected] 

Categories
Press Release

Peripheral Vascular Interventions Market Is Forecast to Rise; Launch of Carnelian Support Catheter by Biotronik Will Accelerate Growth

The increasing prevalence of peripheral artery disease is contributing significantly to the global peripheral vascular interventions market growth says Fortune Business Insights in a report, titled “Peripheral Vascular Interventions Market Size, Share and Global Trend

Rising cases of obesity and high cholesterol are factors driving the global peripheral vascular interventions market.

Browse Complete Report [email protected] https://www.fortunebusinessinsights.com/industry-reports/peripheral-vascular-interventions-market-100722

Top Key Players Covered:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the global Peripheral Vascular Interventions market. Some of the companies operating the global Peripheral Vascular Interventions market are;

  • Edwards Lifesciences Corporation
  • Cardinal Health
  • TERUMO CORPORATION
  • R. Bard, Inc.
  • Braun Melsungen AG
  • Abbott
  • Boston Scientific Corporation
  • AngioScore Inc.
  • Biotronik, Inc.
  • Biosensors International Group, Ltd.
  • Medtronic

Get PDF Brochure of this [email protected] https://www.fortunebusinessinsights.com/enquiry/sample/peripheral-vascular-interventions-market-100722 

Key Segmentation:

By Procedure Type

  • Angioplasty
  • Atherectomy
  • Others

By Implants

  • Stents
  • Catheters
  • Others

By End User

  • Hospitals
  • Ambulatory Surgery Centres
  • Others

Biotronik’s New Treatment Tool Will Encourage Market Growth

Biotronik, a privately held multinational biomedical technology company, announced Carnelian support catheter. The new treatment tool is designed to improve the access for treating of tortuous and highly calcified lesions. The launch of the carnelian tool is expected to promote the peripheral vascular disease nursing interventions owing to the Japanese crossing technique that enables the treatment of very complex lesions.

Minimal Procedural Time in Peripheral Interventions Will Fuel Demand 

Smoking, high cholesterol, obesity, and diabetes are some of the factors responsible for peripheral artery disease. According to the National Heart, Lung and Blood Institute, an estimated 5.0% of population over 50 years suffer due to peripheral artery disease each year in the U.S. Enhanced safety, minimal hospital stays, faster recovery, and minimal procedural time are some factors fueling demand for peripheral vascular disease nursing interventions and thus contributing to peripheral vascular interventions shares. According to the Centers for Disease Control and Prevention, an estimated 8.5 million people in the U.S. are affected by peripheral artery disease, also 10.0-12.0% of the population is 50 years old.

Increasing Cases of Peripheral Artery Disease in The US Will Boost Growth

Geographically, the global peripheral vascular interventions market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America led the global peripheral vascular interventions market in 2017 and is expected to dominate in the forthcoming year owing to rising prevalence of peripheral artery diseases and growing geriatric population. Increasing risk factors for peripheral artery diseases such as obesity and diabetes are fueling demand for peripheral vascular interventions in the region.

More Trending Topics From Fortune Business [email protected]

Global Surgical Lasers Market to Grow with Their Rising Applicability in Oncological Surgeries

Diabetes Devices Market to reach US$ 49,588.2 Mn by 2026, exhibiting a CAGR of 5.5% | Fortune Business Insights

About Us: 

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

 

Categories
Press Release

Global Fish Oil Market to Gain from the Improvements in Fish Farming Techniques Reported Worldwide

Abundant availability of land for fish farming is anticipated to drive the global fish oil market. According to a report by Fortune Business Insights, titled, “Fish Oil Market Size, Share and Global Trend

Fish Oil can aid in the reduction of blood pressure, coronary heart diseases, and bad cholesterol. All these factors are in turn, expected to favor the growth of the global fish oil market.

Browse Complete Report [email protected] https://www.fortunebusinessinsights.com/industry-reports/fish-oil-market-100741

Top Key Players Covered:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the global Fish Oil market. Some of the companies operating the global Fish Oil market are;

  • Croda International PLC.
  • BASF SE
  • DSM
  • FMC Corporation
  • Omega Protein Corporation
  • Copeinca ASA
  • American Marine Ingredients
  • Pelagia AS
  • TripleNine Group
  • Blueline Foods Pvt. Ltd.
  • Sarma Fish SARL
  • GC Rieber

Get PDF Brochure of this [email protected] https://www.fortunebusinessinsights.com/enquiry/sample/fish-oil-market-100741

Rapid Development of Aquaculture Industry to Accelerate Growth in Asia Pacific

The global fish oil is segmented into North America, Europe, the Middle East and Africa, North America, and Asia Pacific. The report states that Europe is projected to lead the global fish oil market during the forecast period. This will occur because the region has been witnessing a rise in the aquaculture activities in countries such as Norway and the U.K. Also, Denmark in Europe is one of the leading producers of fish oil.

Catalent Pharma, Fast&Up, and Other Prominent Market Players Aim to Boost Sales by Launching Innovative Products  

Fast&Up, a vitamin and supplement provider, based in Switzerland, announced the launch of its new product called Promega, an Omega-3 rich fatty acid fish oil in December 2018. Promega promises to improve a person’s immune system, cognitive function, and brain developments. The company is a prominent one amongst several nutritionists and sports enthusiasts. The product is important for optimal health.

These chewables are small and don’t require water. Sona Nutrition Ltd., a producer of herbal remedies and nutritional supplements based in Ireland, announced the launch of ZOMEGA 3 for kids and ZOMEGA for adults. These are two of their most innovative smoothies that include fish oil. The products also contain Vitamin D12, Vitamin K, EPA, Folic Acid, and DHA.

Some of the key companies that are present in the global fish oil market are DSM, Copeinca ASA, Croda International PLC., Blueline Foods Pvt. Ltd., FMC Corporation, TripleNine Group, Omega Protein Corporation, Sarma Fish SARL, American Marine Ingredients, GC Rieber Oils, BASF SE, and Pelagia AS among the other fish oil producers.

More Trending Topics From Fortune Business [email protected]

Intravenous Immunoglobulins Market to Reach US$ 15,789.1 Mn by 2025, Exhibiting A CAGR of 6.2% | Fortune Business Insights

Surgical Sutures Market to Reach US$ 5,982.9 Mn by 2025 with the Recent Launch of New Surgical Sutures by DePuy Synthes, says Fortune Business Insights

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Categories
Press Release

Breast Cancer Therapeutics Market Stand Out as the Biggest Contributor to Global Growth and Will Hit 10.2% CAGR By 2026

According to the report, the global breast cancer therapeutics market, which stood at US$ 17,868.8 Mn in 2018, will reach US$ 38,573.5 Mn by the end of 2026. If these figures prove true, the global breast cancer therapeutics market will rise at a CAGR of 10.2% between 2018 and 2026.

According to the World Health Organization, in 2018, an approximate of 627,000 women, which is tantamount to 15% of all cancer deaths worldwide, succumbed to breast cancer. The rising incidence of breast cancer is one of the chief drivers of the global breast cancer therapeutics market.

Browse Complete Report [email protected] https://www.fortunebusinessinsights.com/industry-reports/breast-cancer-therapeutics-market-100163

KEY INDUSTRY DEVELOPMENTS:

In May 2019, Novartis announced U.S. FDA approval for the company’s new launch of breast cancer therapeutic called Piqray, a PI3K inhibitor for the treatment of advanced breast cancer

In May 2019, Roche announced the U.S. FDA approval of Kadcyla for the adjuvant treatment of individuals with HER2+ early breast cancer with the residual invasive disease after neoadjuvant treatment

In April 2019, Emcure Pharma announced the future launch of the generic version of Eisai Pharma’s breast cancer therapeutic Eribulin (Halaven)

High Intake of Oral Contraceptives Among Women, Boosting Market

Breast cancer can develop due to reasons such as reduced breast feeding, rise in age of childbearing, undergoing estrogen modifying drug treatments and high intake of oral contraceptive pills. The increase in the number of women complaining of such problems and the successive rise in the number of breast cancer cases are factors boosting the global market for breast cancer therapeutics during the forecast period.

Another factor creating lucrative growth opportunities for breast cancer therapies is the increasing number of obese women. With change in lifestyle and unhealthy food habits, the rate of obesity is increasing by the day. Obesity further causes various health problems such as cardiovascular disorders, gall bladder diseases, diabetes, breathing problems, and breast cancer among others.

Get Sample PDF [email protected] https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/breast-cancer-therapeutics-market-100163

By Distribution Channel:

· Hospital Pharmacies
· Retail Pharmacies
· Online Pharmacies

By Geography:

· North America (U.S. and Canada)
· Europe (Germany, U.K., France, Italy, Spain, Scandinavia, and Rest of Europe)
· Asia Pacific (China, India, Japan, Australia, South East Asia and Rest of Asia Pacific)
· Latin America (Brazil, Mexico and Rest of Latin America
· Middle East & Africa (GCC, South Africa and Rest of Middle East & Africa)

North America to Remain Dominant on Account of Presence of Skilled Professionals

The breast cancer treatment market in North America is currently leading the global landscape, supported by the presence of a well-established healthcare infrastructure and rising uptake of advanced facilities in the region. In 2018, North America generated a revenue of US$ 8,033.8 Mn, because of the increasing prevalence of breast cancer in the region. In addition to this, the region boasts presence of several leading market players and skilled professionals.

Besides this, governments of developed nations such as Canada and the U.S. are providing health insurance for cancer diagnostics. Spurred by these factors the breast cancer therapeutics market is likely to flourish in North America to emerge dominant.

Speak to [email protected] https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/breast-cancer-therapeutics-market-100163

TABLE OF CONTENT:

1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions andAssumptions

2. Executive Summary

3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities

4. Key Insights
4.1 Prevalence of BreastCancer Therapeutics by Key Countries
4.2 Regulatory Scenario byKey Regions
4.3 Key IndustryDevelopments
4.4 Overview of CurrentAdvances in R&D for Breast Cancer Therapeutics

Categories
Press Release

Next-generation Sequencing Market Is Expected to Grasp US$ 31,411.3 Mn by 2026, at a CAGR Of 22.2%

Next-Generation Sequencing: Global Market Analysis, Insights and Forecast, 2019-2026 offers a detailed analysis of the competitive landscape and market dynamics. The demand for cost-effective, accurate, and fast DNA sequencing technologies is increasing and this is further giving rise to the dominance of next-generation sequencing platforms. This will further give rise to advanced sequencing technologies for clinical purposes, which is anticipated to drive the market. Increasing advancements in bioinformatics are likely to increase the adoption of next-generation sequencing platforms to facilitate the diagnosis of rare diseases.

As per the report, the global market is expected to rise at a ferocious CAGR of 22.2% between 2018 and 2026. In 2018, the market was worth US$ 6,335.2 Mn and the market will be a howling success as it is projected to reach US$ 31,411.3 Mn by 2026. The demand for next-generation sequencing methodologies is increasing rapidly across several applications such as diagnostics, clinical research among others.

Browse Complete Report [email protected] https://www.fortunebusinessinsights.com/industry-reports/next-generation-sequencing-ngs-market-101000

Demand for Next-Generation Sequencing Services to Rise at a High Pace

Next-generation sequencing products encompass instruments, consumables, and software. According to the findings from the report, the next-generation sequencing product segment is anticipated to lead the market over the forecast period. This is ascribable to some primary factors such as new product launches, high usage of consumables, and easy availability. Apart from next-generation sequencing products, next-generation sequencing services are expected to grow at a higher CAGR during the forecast period.

The need for novel platforms regarding advancements in bioinformatics and fast DNA data interpretation are paving way for start-ups, especially for next-generation sequencing services. With the introduction of next-generation sequencing, the cost of sequencing has reduced over the years. This is positively impacting the growth of this segment. Furthermore, the adoption of next-generation sequencing-based testing is increasing across the world. This, coupled with attractive healthcare reimbursement policies, is expected to drive the segment’s growth in the projected period.

By Geography:

· North America (the USA and Canada)
· Europe (UK, Germany, France, Italy, Spain, and Rest of Europe)
· Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
· Latin America (Brazil, Mexico, and Rest of Latin America)
· Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)

Get Sample PDF [email protected] https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/next-generation-sequencing-ngs-market-101000

North America Leads the Way Owing to Active Government Support

Among regions, North America is anticipated to lead the global next-generation sequencing market through the forecast duration. Rapid developments in precision medicine, next-generation DNA sequencing, and diagnostics are creating growth opportunities for the market. The market is likely to expand as companies in the biotechnology sector are continuously involving in research and development (R&D) activities, which fuels the market demand.

Adapative Technologies developed a next-generation sequencing diagnostic test called ClonoSEQ for patients suffering from acute lymphoblastic leukemia or ALL and minimal residual disease or MRD. The test received FDA approval in September 2018, which in turn, contributes to the growth of the market in North America.

TABLE OF CONTENT:

1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities

4. Key Insights
4.1.Overview of Next-Generation Sequencing Diagnostics Test
4.2.Regulatory Scenario – For Key Countries
4.3.New Product Launch
4.4.Startups with their Funding Overview
4.5.Key industry Developments – Mergers, Acquisitions and Partnerships

Speak to [email protected] https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/next-generation-sequencing-ngs-market-101000

5. Global Next-Generation Sequencing (NGS) Market Analysis, Insights and Forecast, 2015-2026
5.1.Key Findings / Summary

5.2. Market Analysis, Insights and Forecast – By Type
5.2.1. Products
5.2.1.1.Instruments & Software
5.2.1.2.Consumables
5.2.2. Services

5.3. Market Analysis, Insights and Forecast – By Application
5.3.1. Diagnostics
5.3.2. Research
5.3.3. Others

5.4.Market Analysis, Insights and Forecast – By End User
5.4.1. Research Institutes
5.4.2. Healthcare Facilities & Diagnostic Centers
5.4.3. Pharmaceutical & Biotechnological Companies
5.4.4. Contract Research Organization (CROs)

5.5. Market Analysis, Insights and Forecast – By Region
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Latin America
5.5.5. Middle East & Africa

Categories
Press Release

Surgical Sutures Market Share, Industry Outlook, & Global Forecast To 2025

The Global Surgical Sutures Market to gain from rapid technological advancements taking place in the market. Recently Fortune Business Insights has published a report, titled Surgical Sutures Market Size, Share and Global Trend By Product Type (Absorbable, Non-absorbable), Form (Natural, Synthetic), Application (Gynecology, Orthopedics, Cardiology, Ophthalmic, General Surgery), End User (Hospitals, Ambulatory Surgery Centers, Clinics) & Geography Forecast till 2025

Rapid adoption of digitalization among practitioners and patients is likely to fuel the demand in the global Surgical Sutures market. Additionally, increasing per capita income and rising living standards is expected to drive the global Surgical Sutures market during the forecast period 2018-2025.

Browse Complete Report [email protected] https://www.fortunebusinessinsights.com/industry-reports/surgical-sutures-market-100660

Key Segmentation:

By Product Type

  • Absorbable
  • Non-absorbable

By Form

  • Natural
  • Synthetic

By Application

  • Gynecology
  • Orthopedics
  • Cardiology
  • Ophthalmic
  • General Surgery

By End User

  • Hospitals
  • Ambulatory Surgery Centers
  • Clinics

Top Key Players Covered:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the global Surgical Sutures market. Some of the companies operating the global Surgical Sutures market are;

  • CP Medical
  • Demetech Corporation
  • Coloplast Corporation
  • Molnlycke Healthcare
  • BSN Medical
  • Boston Scientific Corporation
  • Internacional Farmacéutica
  • Apollo Endosurgery, Inc.

Get PDF Brochure of this [email protected] https://www.fortunebusinessinsights.com/enquiry/sample/surgical-sutures-market-100660 

As stated in the report North America holds a significant share in the market. The trend is unlikely to change and North America may continue holding its position. The growth witnessed is attributable to high presence of key developers in nations such as Canada and U.S.

The Asia Pacific Surgical Sutures market is expected to expand at a promising CAGR during the forecast period. The constantly improving healthcare infrastructure in the region is expected to contribute to Asia Pacific market expansion.

Major Table of Content For Surgical Sutures Market:

  1. Introduction
  2. Executive Summary
  3. Market Dynamics
  4. Key Insights
  5. Global Surgical Sutures Market Analysis, Insights and Forecast

More Trending Topics From Fortune Business [email protected]

Crop Protection Chemicals (CPC) Market 2019 Research Analysis, Factors, Top Manufacturers, In-depth Study, Product Types, and Regional Demand 2025

Medical Devices Market to Rise at 5.3% CAGR Driven by Rising Geriatric Population and Increasing Healthcare Expenditure, Forecast till 2025

Peritoneal Dialysis Market 2019 | Worldwide Industry Share, Future Demand, Analysis by Top Leading Player and Forecast Till 2025

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: [email protected]

Categories
Press Release

Intravenous Immunoglobulin (IVIG) Market Opportunities and Industry Segments Poised for Rapid Growth by 2025

The rapid adoption of digitalization among practitioners and patients is likely to fuel the demand in the global Intravenous Immunoglobulins market. Additionally, increasing per capita income and rising living standards is expected to drive the global Intravenous Immunoglobulins market during the forecast period 2018-2025.

Browse Complete Report [email protected] https://www.fortunebusinessinsights.com/industry-reports/intravenous-immunoglobulins-market-100593

However, high cost associated with the devices and lack of skilled professional to operate the system are a few factors that may hamper the growth in the global Intravenous Immunoglobulins market.

However, high cost associated with the devices and lack of skilled professional to operate the system are a few factors that may hamper the growth in the global Intravenous Immunoglobulins market. 

As stated in the report North America holds a significant share in the market. The trend is unlikely to change and North America may continue holding its position. The growth witnessed is attributable to high presence of key developers in nations such as Canada and U.S.

The Asia Pacific Intravenous Immunoglobulins market is expected to expand at a promising CAGR during the forecast period. The constantly improving healthcare infrastructure in the region is expected to contribute to Asia Pacific market expansion.

Get PDF Brochure of this [email protected] https://www.fortunebusinessinsights.com/enquiry/sample/intravenous-immunoglobulins-market-100593

TABLE OF CONTENT:

  1. Introduction

1.1.  Research Scope

1.2.  Market Segmentation

1.3.  Research Methodology

1.4.  Definitions and Assumptions

  1. Executive Summary
  2. Market Dynamics

3.1.  Market Drivers

3.2.  Market Restraints

3.3.  Market Opportunities

  1. Key Insights

4.1.  Pipeline Analysis

4.2.  Overview of Regulatory Scenario by Key Regions

4.3.  Key Industry Developments

4.4.  Number (Estimated) of Primary Immunodeficiency (PI) Patients byKey Countries

4.5.  Overview of Reimbursement Scenario

  1. Global Intravenous Immunoglobulins Market Analysis, Insights andForecast, 2015-2026

5.1.  Key Findings /Summary

5.2.  Market Analysis, Insights and Forecast – By Indication

5.2.1.     Primary Immunodeficiency

5.2.2.     Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

5.2.3.     Guillain-Barré Syndrome (GBS)

5.2.4.     Immune Thrombocytopenic Purpura (ITP)

5.2.5.     Multifocal Motor Neuropathy (MMN)

5.2.6.     Others

5.3.  Market Analysis, Insights and Forecast – By Form

5.3.1.     Liquid

5.3.2.     Lyophilized

5.4.  Market Analysis, Insights and Forecast – By End User

5.4.1.     Hospitals

5.4.2.     Clinics

5.4.3.     Homecare

5.5.  Market Analysis, Insights and Forecast – By Region

5.5.1.     North America

5.5.2.     Europe

5.5.3.     Asia Pacific

5.5.4.     Latin America

5.5.5.     Middle East & Africa

Key Segmentation:

By Form

  • Liquid
  • Lyophilized

By End User

  • Hospitals
  • Clinics
  • Homecare

Major Table of Content For Intravenous Immunoglobulins Market:

  1. Introduction
  2. Executive Summary
  3. Market Dynamics
  4. Key Insights
  5. Global Intravenous Immunoglobulins Market Analysis, Insights and Forecast

More Trending Topics From Fortune Business [email protected]

Contraceptive Devices Market 2019 Global Industry Size, Growth Factor Analysis Research Report 2025

Digital Blood Pressure Monitors Industry 2019 Global Market Growth, Size, Demand, Trends, Insights and Forecast 2025

Biopesticides Market 2019 Movements by Revenue Expectation, Growth Status, Trend Analysis, to 2025

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.